Apellis Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2016 to 2023.
  • Apellis Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$133M, a 25.1% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$595M, a 15.8% decline from 2022.
  • Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$514M, a 8.77% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$563M, a 251% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.